Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-02-25

FDA Approved: ONDANSETRON — Supplemental Application (Dr. Reddy's Laboratories Limited)

View source ↗

Summary

FDA approves a supplemental application for a generic ondansetron hydrochloride product from Dr. Reddy's Laboratories Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ondansetron hydrochloride (ondansetron hydrochloride)

Snippet

SUPPL AP for ONDANSETRON (ONDANSETRON HYDROCHLORIDE)